1-2 of 2
Marta Callejas, PhD
Close
Sort by
Journal Articles

Comparison of Clinical Characteristics and Prognosis of a Series of Patients from the Spanish Registry of MDS Diagnosed with Myelodysplastic/Myeloproliferative Neoplasms According to the 2016 Reviewed Classification of the World Health Organization

Blanca Xicoy, María-José Jimenez, Olga García, Marisa Calabuig, MD, Rosa Coll, MD, Elisa Orna, María Teresa Cedena, Ana Vicente, Eugenia Rivero, Itziar Oiartzabal Ormategui, Lurdes Zamora, PhD, Jose-Angel Hernandez, MD, Natalia Estrada, Marta Callejas, PhD, Bernardo Javier González González, Raquel de Paz, Montserrat Cortes, Laura Palomo, MSc, Joan Bargay, MD PhD, María-Lavinia Villalobos, Alicia Bailen, María-Ángeles Montañés, Teresa Bernal Del Castillo, MD PhD, Félix López Cadenas, MD, Javier Grau, Salut Brunet, MD PhD, Ana Jiménez, Guillermo Sanz, Josefa Marco, Tzu Hua Chen-Liang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3048.
https://doi.org/10.1182/blood-2018-99-111883
Published: 2018
Journal Articles

Impact of Comorbidities In Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Treated with Azacitidine (AZA)

Patricia Font, PhD, Valle Gomez Garcia De Soria, PhD, Javier Loscertales, PhD, Julio Garcia Suarez, PhD, Marta Callejas, PhD, Carmen Burgaleta, PhD, Santiago Osorio, PhD, Carlos Soto, PhD, Lucia Villalon, PhD, Jose Diez-Martin, Ana Villegas, PhD
Journal: Blood
Blood (2010) 116 (21): 4973.
https://doi.org/10.1182/blood.V116.21.4973.4973
Published: 2010